title: Differential functions of phospholipid binding and palmitoylation of tumour suppressor EWI2/PGRL.
abstract: The tumour suppressor EWI2 associates with tetraspanins and regulates tumour cell movement and proliferation. The short cytoplasmic domain of EWI2 is positively charged; five out of the ten residues of this domain are basic. In the present study we demonstrated that the EWI2 cytoplasmic tail interacts specifically with negatively charged PIPs (phosphatidylinositol phosphates), but not with other membrane lipids. The PIPs that interact with EWI2 cytoplasmic tail include PtdIns5P, PtdIns4P, PtdIns3P, PtdIns(3,5)P(2) and PtdIns(3,4)P2. The binding affinity of PIPs to the EWI2 tail, however, is not solely based on charge because PtdIns5P, PtdIns4P and PtdIns3P have a higher affinity to EWI2 than PtdIns(3,5)P(2) and PtdIns(3,4)P(2) do. Mutation of either of two basic residue clusters in the EWI2 cytoplasmic tail abolishes PIP binding, and PIP binding is also determined by the position of basic residues in the EWI2 cytoplasmic tail. In addition, EWI2 is constitutively palmitoylated at the cytoplasmic cysteine residues located at the N-terminal of those basic residues. The PIP interaction is not required for, but appears to regulate, the palmitoylation, whereas palmitoylation is neither required for nor regulates the PIP interaction. Functionally, the PIP interaction regulates the stability of EWI2 proteins, whereas palmitoylation is needed for tetraspanin-EWI2 association and EWI2-dependent inhibition of cell migration and lamellipodia formation. For cell-cell adhesion and cell proliferation, the PIP interaction functions in opposition to the palmitoylation. In conclusion, the EWI2 cytoplasmic tail actively engages with the cell membrane via PIP binding and palmitoylation, which play differential roles in EWI2 functions.
authors: Vascular Biology Center, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
authors: Bo
authors: B
authors: He
authors: Yanhui H
authors: YH
authors: Zhang
authors: Mekel M
authors: MM
authors: Richardson
authors: Julian S
authors: JS
authors: Zhang
authors: Eric
authors: E
authors: Rubinstein
authors: Xin A
authors: XA
authors: Zhang
references: J Biol Chem. 2005 Feb 4;280(5):3346-54
references: 15557282
references: J Biol Chem. 2001 Nov 2;276(44):40545-54
references: 11504738
references: J Immunol. 2001 Nov 1;167(9):5115-21
references: 11673522
references: Annu Rev Physiol. 2003;65:761-89
references: 12471164
references: J Cell Biol. 2005 Dec 19;171(6):1061-71
references: 16344308
references: J Biol Chem. 1997 Jan 31;272(5):2595-8
references: 9006891
references: Traffic. 2003 Apr;4(4):201-13
references: 12694559
references: Nat Rev Mol Cell Biol. 2005 Oct;6(10):801-11
references: 16314869
references: Science. 2001 Nov 30;294(5548):1942-5
references: 11729323
references: Cell Mol Biol Lett. 2005;10(4):711-9
references: 16341279
references: J Biol Chem. 2001 Jul 6;276(27):25005-13
references: 11325968
references: Chem Phys Lipids. 1999 Aug;101(1):109-21
references: 10810929
references: Trends Biochem Sci. 2001 Oct;26(10):604-11
references: 11590013
references: J Biol Chem. 2004 Jan 2;279(1):704-12
references: 14570906
references: Neoplasia. 2009 Jan;11(1):77-86, 4p following 86
references: 19107234
references: J Biol Chem. 2001 Feb 16;276(7):4853-62
references: 11087758
references: Blood. 2004 Apr 15;103(8):3013-9
references: 15070678
references: Mol Biol Cell. 2002 Jan;13(1):1-11
references: 11809818
references: Nat Rev Neurosci. 2002 Oct;3(10):791-802
references: 12360323
references: Nat Rev Mol Cell Biol. 2007 Jan;8(1):74-84
references: 17183362
references: Nat Protoc. 2007;2(7):1573-84
references: 17585299
references: Cancer Res. 2003 May 15;63(10):2665-74
references: 12750295
references: J Cell Sci. 2005 May 15;118(Pt 10):2093-104
references: 15890985
references: Biotechniques. 2004 Feb;36(2):276-85
references: 14989092
references: Nat Cell Biol. 2004 Jun;6(6):487-92
references: 15170460
references: Cancer Lett. 2006 Aug 28;240(2):183-94
references: 16260083
references: Trends Cell Biol. 2003 Jan;13(1):32-42
references: 12480338
references: Trends Immunol. 2003 Nov;24(11):610-7
references: 14596886
references: Biochim Biophys Acta. 1999 Aug 12;1451(1):1-16
references: 10446384
references: J Biol Chem. 2006 Jul 14;281(28):19665-75
references: 16690612
references: Cell Mol Life Sci. 2001 Aug;58(9):1189-205
references: 11577978
references: Mol Cell Biol. 2007 Nov;27(21):7718-26
references: 17785435
references: Nature. 2006 Oct 12;443(7112):651-7
references: 17035995
references: Nat Rev Immunol. 2005 Feb;5(2):136-48
references: 15688041
references: J Cell Biol. 2003 Dec 8;163(5):1167-77
references: 14662754
references: Biochem J. 2003 Jul 15;373(Pt 2):409-21
references: 12708969
references: Physiol Rev. 2004 Jul;84(3):699-730
references: 15269334
references: Biochem J. 2009 Jul 29;422(1):23-35
references: 19508231
references: J Biol Chem. 2001 Apr 27;276(17):14329-37
references: 11278880
references: Science. 2001 Nov 30;294(5548):1881-5
references: 11729306
references: J Biol Chem. 2007 Oct 26;282(43):31631-42
references: 17716972
references: Eur J Cell Biol. 2008 Apr;87(4):251-66
references: 18191498